Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Capital Leases: 2019-2022

Historic Capital Leases for Agios Pharmaceuticals (AGIO) over the last 1 years, with Mar 2022 value amounting to $276,000.

  • Agios Pharmaceuticals' Capital Leases rose 11.29% to $276,000 in Q1 2022 from the same period last year, while for Mar 2022 it was $276,000, marking a year-over-year increase of 11.29%. This contributed to the annual value of $276,000 for FY2021, which is 16.62% down from last year.
  • As of Q1 2022, Agios Pharmaceuticals' Capital Leases stood at $276,000, which was down 0.00% from $276,000 recorded in Q4 2021.
  • Agios Pharmaceuticals' 5-year Capital Leases high stood at $673,000 for Q4 2019, and its period low was $167,000 during Q2 2021.
  • Over the past 3 years, Agios Pharmaceuticals' median Capital Leases value was $276,000 (recorded in 2022), while the average stood at $285,000.
  • Per our database at Business Quant, Agios Pharmaceuticals' Capital Leases tumbled by 50.82% in 2020 and then grew by 11.29% in 2022.
  • Quarterly analysis of 4 years shows Agios Pharmaceuticals' Capital Leases stood at $673,000 in 2019, then tumbled by 50.82% to $331,000 in 2020, then dropped by 16.62% to $276,000 in 2021, then rose by 11.29% to $276,000 in 2022.
  • Its Capital Leases was $276,000 in Q1 2022, compared to $276,000 in Q4 2021 and $167,000 in Q2 2021.